ViewRay Systems
ViewRay Systems designs and markets the MRIdian A3i, an MRI-guided radiation therapy system combining diagnostic MRI imaging, radiation delivery, and proprietary software for real-time tumor tracking, sold via direct enterprise sales to hospitals and cancer treatment centers in the US and UK.
- Company typePrivate
- Founded2024
- HeadquartersOakwood Village, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What ViewRay Systems does
ViewRay Systems, Inc. is a privately held medical device company that designs, manufactures, and markets the MRIdian A3i Radiation Therapy System, an MRI-guided radiotherapy platform integrating diagnostic-quality MRI imaging, radiation delivery hardware, and proprietary software. The system's core differentiator is real-time soft-tissue tracking with automated beam control, which enables clinicians to visualize tumors continuously, eliminate reliance on implanted fiducial markers, and adapt radiation dose to anatomical changes during treatment. It is positioned for pancreatic, prostate, lung, liver, breast, and oligometastatic cancers, with peer-reviewed clinical evidence cited as showing reduced side effects and extended survival.
The company was established on February 6, 2024, after acquiring all assets of the predecessor ViewRay, Inc., including intellectual property, physical inventory, software, service tools and procedures, quality management systems, device technical documentation files, and production records. Operations are headquartered in Oakwood Village, Ohio, with additional offices in Denver, Colorado and Milpitas, California. Go-to-market is direct enterprise sales to hospitals and cancer treatment centers globally, supported by marketing aimed at both clinicians (scientific presentations, webinars) and patients (patient success stories, disease-specific educational content). The business model combines one-time capital equipment sales with recurring service and support revenue on the installed base, and the MRIdian A3i is sized to fit within standard radiation therapy vaults, reducing facility modification barriers for prospective buyers.
The company operates in the United States and the United Kingdom, with named hospital and cancer center customers including Dana-Farber Cancer Institute, Moffitt Cancer Center, UCLA, NewYork-Presbyterian Weill Cornell, Brigham and Women's Hospital, Providence Cancer Institute, Miami Cancer Institute, Hoag Hospital, Tower Health, and GenesisCare (both Fort Myers and Oxford). ViewRay Systems maintains an active social presence across LinkedIn, X, Facebook, and Instagram, and publishes clinician-facing webinars and scientific presentations to drive demand among radiation oncology professionals.
ViewRay Systems firmographics
Firmographics- Name
- ViewRay Systems
- Legal name
- ViewRay Systems, Inc.
- Website
- https://viewraysystems.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Short description
- ViewRay Systems designs and markets the MRIdian A3i, an MRI-guided radiation therapy system combining diagnostic MRI imaging, radiation delivery, and proprietary software for real-time tumor tracking, sold via direct enterprise sales to hospitals and cancer treatment centers in the US and UK.
- Ownership category
- akta.pro rank
ViewRay Systems industry classification
Industry- Product category
- Radiation Therapy Systems
- NAICS
- Irradiation Apparatus Manufacturing (334517)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)
- akta.pro secondary industries
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Magnetic Resonance Imaging (MRI) Systems (HLAHABAC)
Keywords
Where ViewRay Systems is headquartered
LocationHeadquarters
- HQ city
- Oakwood Village
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ViewRay Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- MRIdian A3i Radiation Therapy System Sales: Sale of the MRIdian A3i Radiation Therapy System, a medical device that integrates MRI technology, radiation delivery, and proprietary software. The system is sold to hospitals and cancer treatment centers for cancer treatment.
- Service and Support: Ongoing service, maintenance, and technical support for installed MRIdian systems.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
ViewRay Systems product offering
Product offeringCore offering
ViewRay Systems designs, manufactures, and markets the MRIdian A3i Radiation Therapy System, an MRI-guided radiotherapy platform that combines diagnostic-quality MRI imaging with linear accelerator radiation delivery and proprietary software for real-time tumor tracking and automated beam control. The system is sold to hospitals and cancer treatment centers and is used to treat pancreatic, prostate, lung, liver, breast, and oligometastatic cancers. The company also provides ongoing service, maintenance, and technical support for installed MRIdian systems.
Product overview
ViewRay Systems offers a single unified medical device product: the MRIdian A3i Radiation Therapy System. This MRI-guided radiation therapy system integrates MRI imaging technology, radiation delivery, and proprietary software into one platform. The system enables clinicians to visualize soft tissue in real-time, shape radiation doses to accommodate anatomical changes, and deliver precise radiation targeting throughout treatment. It is designed for treating various cancers including pancreatic, prostate, lung, liver, breast, and oligometastatic cancers.
Differentiator
Problem solved
Functional benefit
Brands
- MRIdian A3i: MRI-Guided Radiation Therapy System that integrates MRI technology, radiation delivery, and proprietary software for real-time tumor targeting and treatment delivery
Products and services
- MRIdian A3i Radiation Therapy System An MRI-guided radiotherapy system that integrates diagnostic-quality MRI imaging, linear accelerator radiation delivery, and proprietary software for real-time tissue tracking and automated beam control. It is sold to hospitals, cancer centers, and radiation oncology departments and is used to treat pancreatic, prostate, lung, liver, breast, and oligometastatic cancers.
- MRIdian Service and Support Ongoing service, maintenance, and technical support provided to hospitals and cancer centers for installed MRIdian radiation therapy systems.
Quantifiable outcome
- Reduced side effects and extended survival demonstrated through peer-reviewed evidence
Companies that use ViewRay Systems
Customer profileNamed customers11 records
Segments1 record
Ideal customer profiles1 record
ViewRay Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
ViewRay Systems partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
ViewRay Systems competitors and assessment
Company assessmentBroad incumbents
- Hitachi: Through its proton therapy and diagnostic imaging businesses, Hitachi participates in the advanced radiation oncology equipment market that ViewRay serves.
- GE HealthCare: Supplies MRI systems, CT simulators, and radiotherapy imaging solutions to cancer centers, overlapping with the imaging infrastructure that surrounds MRIdian installations.
- Siemens Healthineers: Owns Varian and supplies MRI scanners, CT, linear accelerators, and imaging-guided therapy infrastructure — overlapping with ViewRay across the imaging-and-radiotherapy stack from a much broader portfolio.
- Philips: Global medical imaging and radiation oncology vendor (Ingenia MRI, Big Bore RT, Pinnacle treatment planning) that competes for hospital imaging-and-therapy capital dollars adjacent to MRIdian.
Emerging players
- RaySearch Laboratories: Develops treatment planning and oncology informatics software (RayStation, RayCare) used alongside advanced Linac and MR-Linac systems, addressing adjacent layers of the MRIdian ecosystem.
- Brainlab: Provides radiation oncology software, treatment planning, and image-guided surgery platforms that increasingly bundle with or compete around MR-guided therapy workflows.
Direct peers
- Elekta: Maker of the Unity MR-Linac system, the only other commercially available integrated MRI-guided linear accelerator and ViewRay's primary head-to-head competitor in the MR-guided radiation therapy category.
- Accuray: Develops and sells CyberKnife and TomoTherapy/Helical systems for stereotactic and image-guided radiation therapy, competing in the same hospital capital-equipment category as MRIdian.
- IBA (Ion Beam Applications): Supplies proton therapy and other advanced radiotherapy systems to cancer centers, competing for the same high-end radiation oncology capital equipment budgets as MRIdian.
- Varian Medical Systems: A Siemens Healthineers subsidiary and historically dominant supplier of conventional Linac-based radiation therapy systems (TrueBeam, Edge, Halcyon) that compete with MRIdian for hospital radiotherapy capital budgets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
ViewRay Systems social profiles
Digital presenceViewRay Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
ViewRay Systems leadership team
Management profileNumber of profiles
ViewRay Systems funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ViewRay Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ViewRay Systems
What does ViewRay Systems do?
ViewRay Systems designs, manufactures, and markets the MRIdian A3i Radiation Therapy System, an MRI-guided radiotherapy platform that combines diagnostic-quality MRI imaging with linear accelerator radiation delivery and proprietary software for real-time tumor tracking and automated beam control. The system is sold to hospitals and cancer treatment centers and is used to treat pancreatic, prostate, lung, liver, breast, and oligometastatic cancers. The company also provides ongoing service, maintenance, and technical support for installed MRIdian systems.
Is ViewRay Systems a public or private company?
ViewRay Systems is a private company. It is classified as unknown and is currently operating.
When was ViewRay Systems founded?
ViewRay Systems was founded in 2024.
Where is ViewRay Systems based?
ViewRay Systems is headquartered in Oakwood Village, United States, in the North America region.
How does ViewRay Systems make money?
Two revenue lines are on record. MRIdian A3i Radiation Therapy System Sales are the primary driver. The others are service and Support.
Who are ViewRay Systems's main competitors?
Broad incumbents on record are Hitachi, GE HealthCare, Siemens Healthineers and Philips. Emerging players are RaySearch Laboratories and Brainlab. Direct peers are Elekta, Accuray, IBA (Ion Beam Applications) and Varian Medical Systems.
Does ViewRay Systems have an API?
No public API is recorded for ViewRay Systems.
What industry is ViewRay Systems in?
ViewRay Systems's product category is Radiation Therapy Systems. Its primary akta.pro industry code is HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim), with a secondary code of HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems. Its NAICS code is 334517 and its SIC code is 3841.